Table 5.
FMEA/FMECA of the pre-bioprinting phase and cell preparation sub-phase.
Step | Activity | Failure Mode | Potential Cause | Possible Consequences | O | S | D | RPN | Mitigation Actions |
---|---|---|---|---|---|---|---|---|---|
MSC selection type |
Clinical need evaluation/Source choice | Inappropriate cell type selection | Inadequate cell response | Impaired chondroprotective cell potential | 5 | 8 | 8 | 320 | Definition of new selection criteria |
MSC culture |
Cell isolation | Microbial contamination Cell death/low cell growth Non-idoneous cell number/passage Impaired cell phenotype |
Human error, low instrument performance Improper culture conditions Sample variability |
No adequate cell availability to continue the process Delay in experimental plan |
4 | 10 | 2 | 80 | Periodic instrument controls (calibration) Optimization of culture conditions Definition of strict criteria for sample processing Personnel training |
Cell characterization | Microbial contamination Cell death/low cell growth Non-idoneous cell number/passage Impaired cell phenotype |
Human error, low instrument performance Improper culture conditions Sample variability |
No adequate cell availability to continue the process Delay in experimental plan |
5 | 9 | 2 | 90 | Periodic instrument controls (calibration) Optimization of culture conditions Definition of stricter criteria for sample processing Personnel training |
|
MSC culture |
Cell expansion | Microbial contamination Cell death/low cell growth Non-idoneous cell number/passage Impaired cell phenotype |
Human error, low instrument performance Improper culture conditions Sample variability |
No adequate cell availability to continue the process Delay in experimental plan |
8 | 6 | 2 | 96 | Periodic instrument controls (calibration) Optimization of culture conditions Definition of stricter criteria for sample processing Personnel training |
MSC suspension preparation |
Cell harvest | Low cell growth | Human error Improper culture conditions Sample variability |
Lower than planned yield A high amount of cell death Delay in the experimental plan |
4 | 6 | 2 | 48 | Optimization of culture conditions Definition of more stringent criteria for sample processing Personnel training |
Cell characterization | Impaired cell phenotype/function | Improper culture conditions | Wrong/non-idoneous cell population | 6 | 9 | 2 | 108 | Periodic instrument controls (calibration) Optimization of culture conditions Optimization of culture conditions |
|
Medium definition for cell suspension | Impaired cell viability | Improper culture conditions |
High cell death during post-printing phase | 6 | 10 | 6 | 360 | Optimization of culture medium for cell suspension |